CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in the $5.5 Billion ...

Cingulate (CING) has received a $3M grant to accelerate the development of CTx-2103 for the treatment of anxiety. CTx-2103 has the potential to be the first, once-daily formulation of buspirone ...

Alivus Life Sciences Ltd share price was up by 2.59% ... this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited ...

ERIS Lifesciences Ltd share price was up by 2. ... on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and ...

Eris Lifesciences, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹1372.3. The stock has experienced fluctuations today ...

Apr. 8, 2025 — A new study maps how specific lactic acid bacteria can enhance both the flavor and nutritional quality of plant-based dairy alternatives. The findings may have wide-reaching ...

Evolution and innovation are critical to the field of life sciences, with each year bringing new challenges and breakthroughs. This holds especially true in the built environment — the labs ...

Even for an industry that depends on relentless innovation to thrive, life sciences have seen remarkable advancements in recent decades. From the Human Genome Project paving the way for precision ...

Bacteria can be engineered to sense a variety of molecules, such as pollutants or soil nutrients. In most cases, however, these signals can only be detected by looking at the cells under a ...

Life Pharmaceuticals PVT LTD is a Non-govt company, incorporated on 13 Nov, 1964. It's a private unlisted company and is classified as'company limited by shares'. Company's authorized capital stands ...

ERIS Lifesciences Limited is a pharmaceutical company specializing in the manufacturing and marketing of branded formulations, primarily targeting chronic and lifestyle-related therapies. With a ...